JPRN-UMIN000017095
Completed
未知
A randomized double-blind placebo-controlled study for effects of aged garlic extract on fatigue - A study for effects of aged garlic extract on fatigue
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Momoya Co., Ltd.
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Subjects who are allergic to products related to the test material of this study. 2\) Subjects who are addicted to alcohol or has an extremely irregular dietary habit. 3\) Subjects who take drugs, quasi\-drugs, dietary supplements, health foods or something other which possibly have effects on this study. 4\) Patients with organic diseases which apparently induce fatigue. 5\) Subjects who are pregnant or breastfeeding, or desires to get pregnant during the study period. 6\) Subjects who are judged unsuitable for this study by principal investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Efficacy of Ashwagandha extract on generalized anxiety disorderCTRI/2022/04/042133Arjuna Natural Private Limited60
Active, not recruiting
Phase 1
ALASCCA-A randomized double-blind placebo-controlled study with ASAtreatment in colorectal cancer patients with mutations in the PI3Ksignaling pathway.Colon or rectal cancer tumor stage II-III, tumor with somatic alterationsin PIK3CA, PIK3R1 or PTEN.MedDRA version: 21.0Level: LLTClassification code 10010029Term: Colorectal cancer NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2015-004240-19-DKKarolinska University Hospital, Department of Molecular medicine and Surgery Karolinska Institutet, Gastrocentrum600
Not yet recruiting
Phase 3
ALASCCA-A randomized double-blind placebo-controlled study with ASA treatment in colorectal cancer patients with mutations in the PI3K signaling pathway2024-513778-23-00Karolinska Institutet700
Not yet recruiting
Not Applicable
A randomized double-blind placebo-controlled study of Qingfei Jianpi desensitization prescription in early intervention of seasonal allergic rhinitisallergic rhinitisITMCTR2200006028Beijing Tongren Hospital ,Capital Medical University
Recruiting
Phase 3
A randomized double-blind placebo-controlled study to evaluate the efficacy and safety of Cinryze® (C1 esterase inhibitor [human]) for the treatment of acute antibody-mediated rejection in kidney transplant patientskidney transplant10038430NL-OMON44758Shire7